Spasticity after stroke: Physiology, assessment and treatment

Brain Injury

Volumn 27, Issue 10, 2013, Pages 1093-1105

  Thibaut, Aurore ^a   Chatelle, Camille ^a   Ziegler, Erik ^b   Bruno, Marie Aurélie ^a   Laureys, Steven ^a   Gosseries, Olivia ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Physiotherapy; Spasticity; Stroke; Treatment; Upper motoneuron syndrome

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLONAZEPAM; DANTROLENE; DIAZEPAM; GABAPENTIN; PHENOL; TIZANIDINE;

ADDICTION; ADVERSE OUTCOME; ATAXIA; BABINSKI REFLEX; BEDTIME DOSAGE; BEHAVIOR; BURNING SENSATION; CEREBROVASCULAR ACCIDENT; CLONUS; CONFUSION; CONTRACTURE; CRANIAL NEUROPATHY; CRYOTHERAPY; DAILY FUNCTIONAL ASSESSMENT SCALE; DEPRESSION; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG MECHANISM; DRUG SAFETY; DYSESTHESIA; DYSPHAGIA; ELECTROPHYSIOLOGY; FAINTNESS; FATIGUE; GAIT; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMIPARESIS; HUMAN; HYDROTHERAPY; HYPERTHERMIC THERAPY; HYPOTENSION; INFANTILE SPASM; INJECTION SITE PAIN; JOINT FUNCTION; KINGS HYPERTONICITY SCALE; LIVER TOXICITY; MEMORY DISORDER; MIDDLE FRONTAL GYRUS; MODIFIED ASHWORTH SCALE; MODIFIED TARDIEU SCALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; MUSCLE WEAKNESS; NAUSEA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; ORTHOSIS; PAIN; PASSIVE MOVEMENT; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PHYSIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; RATING SCALE; REHABILITATION CARE; RESPIRATORY DISTRESS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SPASTICITY; TENDON REFLEX; TONE ASSESSMENT SCALE; TRANSCUTANEOUS NERVE STIMULATION; TREMOR; VOLUNTARY MOVEMENT; WEAKNESS;

BOTULINUM TOXINS, TYPE A; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MUSCLE SPASTICITY; NERVE BLOCK; NEUROIMAGING; NEUROMUSCULAR AGENTS; ORTHOPEDIC PROCEDURES; ORTHOTIC DEVICES; PARASYMPATHOLYTICS; PHYSICAL THERAPY MODALITIES; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; STROKE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 84881419504     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2013.804202     Document Type: Review

References (126)

1. Lance J. Spasticity: Disorders motor control. In: Feldman RG, Young RP, Koella WP editors. Symposium synopsis. Miami, FL: Year Book Medical Publishers; 1980.
2. Young RR. Spasticity: A review. Neurology 1994;44(S9):S12-S20.
3. Dietz V, Sinkjaer T. Spastic movement disorder: Impaired reflex function and altered muscle mechanics. Lancet Neurology 2007;6: 725-733. (Pubitemid 47058387)
4. McComas AJ. Human neuromuscular adaptations that accompany changes in activity. Medicine & Science in Sports & Exercise 1994; 26:1498-1509.
5. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations. Stroke 2004;35: 134-139. (Pubitemid 38057606)
6. Mayer NH, Esquenazi A. Muscle overactivity and movement dysfunction in the upper motoneuron syndrome. Physical Medicine & Rehabilitation Clinics of North America 2003;14:855-883, vii-viii. (Pubitemid 37243725)
7. Ward AB. A literature review of the pathophysiology and onset of post-stroke spasticity. European Journal of Neurology 2012;19: 21-27.
8. Wissel J, Schelosky LD, Scott J, Christe W, Faiss JH, Mueller J. Early development of spasticity following stroke: A prospective, observational trial. Journal of Neurology 2010;257:1067-1072.
9. Hefter H, Jost WH, Reissig A, Zakine B, Bakheit AM, Wissel J. Classification of posture in poststroke upper limb spasticity: A potential decision tool for botulinum toxin A treatment? International Journal of Rehabilitation Research 2012;35:227-233.
10. Marciniak C. Poststroke hypertonicity: Upper limb assessment and treatment. Topics in Stroke Rehabilitation 2011;18:179-194.
11. Urban PP, Wolf T, Uebele M, Marx JJ, Vogt T, Stoeter P, Bauermann T, Weibrich C, Vucurevic GD, Schneider A, Wissel J. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke 2010;41:2016-2020.
12. Coupar F, Pollock A, Rowe P, Weir C, Langhorne P. Predictors of upper limb recovery after stroke: A systematic review and metaanalysis. Clinical Rehabilitation 2012;26:291-313.
13. Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, Katz RC, Lamberty K, Reker D. Management of adult stroke rehabilitation care: A clinical practice guideline. Stroke 2005;36: E100-143.
14. Brown P. Pathophysiology of spasticity. Journal of Neurology, Neurosurgery & Psychiatry 1994;57:773-777. (Pubitemid 24214953)
15. Doan QV, Brashear A, Gillard PJ, Varon SF, Vandenburgh AM, Turkel CC, Elovic EP. Relationship between disability and healthrelated quality of life and caregiver burden in patients with upper limb poststroke spasticity. Polymyalgia Rheumatica 2012;4:4-10.
16. Ivanhoe C, Reistetter T. Spasticity: The misunderstood part of the upper motor neuron syndrome. American Journal of Physical Medicine & Rehabilitation 2004;83:S3-S9. (Pubitemid 39281263)
17. Sheean G. The pathophysiology of spasticity. European Journal of Neurology 2002;9:3-9. (Pubitemid 41759594)
18. Soyuer F, Ozturk A. The effect of spasticity, sense and walking aids in falls of people after chronic stroke. Disability & Rehabilitation 2007;29:679-687. (Pubitemid 46672324)
19. Binkofski F, Seitz RJ, Arnold S, Classen J, Benecke R, Freund HJ. Thalamic metbolism and corticospinal tract integrity determine motor recovery in stroke. Annals of Neurology 1996;39:460-470. (Pubitemid 26118001)
20. Pandyan A, Gregoric M, Barnes M. Spasticity: Clinical perceptions, neurological realities and meaningful measurement. Disability & Rehabilitation 2005;27:2-6. (Pubitemid 40124834)
21. Marque P, Simonetta-Moreau M, Maupas E, Roques CF. Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients. Journal of Neurology, Neurosurgery & Psychiatry 2001;70:36-42. (Pubitemid 32096118)
22. Averbeck BB, Chafee MV, Crowe DA, Georgopoulos AP. Neural activity in prefrontal cortex during copying geometrical shapes. I. Single cells encode shape, sequence, and metric parameters. Experimental Brain Research 2003;150:127-141. (Pubitemid 36606378)
23. Hanakawa T, Immisch I, Toma K, Dimyan MA, Van Gelderen P, Hallett M. Functional properties of brain areas associated with motor execution and imagery. Journal of Neurophysiology 2003;89: 989-1002. (Pubitemid 36206146)
24. Kalaska JF, Cisek P, Gosselin-Kessiby N. Mechanisms of selection and guidance of reaching movements in the parietal lobe. Advances in Neurology 2003;93:97-119.
25. Sirigu A, Daprati E, Ciancia S, Giraux P, Nighoghossian N, Posada A, Haggard P. Altered awareness of voluntary action after damage to the parietal cortex. Nature Neuroscience 2004;7: 80-84. (Pubitemid 38032172)
26. Sirigu A, Duhamel JR, Cohen L, Pillon B, Dubois B, Agid Y. The mental representation of hand movements after parietal cortex damage. Science 1996;273:1564-1568.
27. Ward NS, Brown MM, Thompson AJ, Frackowiak RS. Neural correlates of motor recovery after stroke: A longitudinal fMRI study. Brain 2003;126:2476-2496. (Pubitemid 37314437)
28. Newham DJ, Hsiao SF. Knee muscle isometric strength, voluntary activation and antagonist co-contraction in the first six months after stroke. Disability & Rehabilitation 2001;23:379-386. (Pubitemid 32492719)
29. Riley NA, Bilodeau M. Changes in upper limb joint torque patterns and EMG signals with fatigue following a stroke. Disability & Rehabilitation 2002;24:961-969. (Pubitemid 36032859)
30. Gemperline JJ, Allen S, Walk D, Rymer WZ. Characteristics of motor unit discharge in subjects with hemiparesis. Muscle & Nerve 1995;18:1101-1114.
31. Rosenfalck A, Andreassen S. Impaired regulation of force and firing pattern of single motor units in patients with spasticity. Journal of Neurology, Neurosurgery & Psychiatry 1980;43: 907-916. (Pubitemid 11250735)
32. Jakobsson F, Grimby L, Edstrom L. Motoneuron activity and muscle fibre type composition in hemiparesis. Scandinavian Journal of Rehabilitation Medicine 1992;24:115-119.
33. Berg HE, Larsson L, Tesch PA. Lower limb skeletal muscle function after 6 wk of bed rest. Journal of Applied Physiology 1997;82:182-188. (Pubitemid 27052059)
34. Ferretti G, Berg HE, Minetti AE, Moia C, Rampichini S, Narici MV. Maximal instantaneous muscular power after prolonged bed rest in humans. Journal of Applied Physiology 2001;90:431-435. (Pubitemid 32118899)
35. McLachlan EM. Rapid atrophy of mouse soleus muscles after tenotomy depends on an intact innervation. Neuroscience Letters 1981;25:269-274. (Pubitemid 12254832)
36. McLachlan EM, Chua M. Rapid adjustment of sarcomere length in tenotomized muscles depends on an intact innervation. Neuroscience Letters 1983;35:127-133. (Pubitemid 13120716)
37. McLachlan EM. Atrophic effects of proximal tendon transection with and without denervation on mouse soleus muscles. Experimental Neurology 1983;81:651-668.
38. Williams PE, Goldspink G. Connective tissue changes in immobilised muscle. Journal of Anatomy 1984;138:343-350. (Pubitemid 14125067)
39. Esquenazi A. Evaluation and management of spastic gait in patients with traumatic brain injury. Journal of Head Trauma Rehabiliation 2004;19:109-118. (Pubitemid 38437137)
40. Bohannon R, Smith M. Inter rater reliability of a modified Ashworth Scale of muscle spasticity. Physical Therapy 1987;67: 206-207. (Pubitemid 17026064)
41. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité. Revista de Neurología 1954;91:143-144.
42. Held J, Pierrot-Deseilligny E. Reeducation Motrice des Affections Neurologiques. Paris: J.B. Bailleres; 1969.
43. Pandyan A, et al. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clinical Rehabilitation 1999;13:373-383. (Pubitemid 29425632)
44. Brashear A, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. New England Journal of Medicine 2002;347:395-400. (Pubitemid 34851831)
45. Brashear A, Zafonte R, Corcoran M, Galvez-Jimenez N, Gracies JM, Gordon MF, McAfee A, Ruffing K, Thompson B, Williams M, Lee CH, Turkel C. Inter-and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upperlimb poststroke spasticity. Archives of Physical Medicine & Rehabilitation 2002;83:1349-1354.
46. Gracies JM, Fitzpatrick R, Wilson L, Burke D, Gandevia SC. Lycra garments designed for patients with upper limb spasticity: Mechanical effects in normal subjects. Archives of Physical Medicine & Rehabilitation 1997;78:1066-1071. (Pubitemid 27431287)
47. Lee KC, Carson, L, Kinnin, E, Patterson, V. The Ashworth Scale: A reliable and reproducible method of measuring spasticity. Journal of Neurological Rehabilitation 1989;3:205-209.
48. Ghotbi N, Nakhostin Ansari N, Naghdi S, Hasson S. Measurement of lower-limb muscle spasticity: Intrarater reliability of Modified Modified Ashworth Scale. Journal of Rehabilitation Researh & Development 2011;48:83-88.
49. Mehrholz J, Major Y, Meissner D, Sandi-Gahun S, Koch R, Pohl M. The influence of contractures and variation in measurement stretching velocity on the reliability of the Modified Ashworth Scale in patients with severe brain injury. Clinical Rehabilitation 2005;19:63-72.
50. Gracies JM, Burke K, Clegg NJ, Browne R, Rushing C, Fehlings D, Matthews D, Tilton A, Delgado MR. Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Archives of Physical Medicine & Rehabilitation 2010;91:421-428.
51. Thakker MM, Rubin PA. Pharmacology and clinical applications of botulinum toxins A and B. International Ophthalmology Clinics 2004;44:147-163. (Pubitemid 38955667)
52. Boyd R, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A in the management of spasticity in children with cerebral palsy. European Journal of Neurology 1999;6:23-36.
53. Mehrholz J, Wagner K, Meissner D, Grundmann K, Zange C, Koch R, Pohl M. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: A comparison study. Clinical Rehabilitation 2005;19:751-759. (Pubitemid 41489529)
54. Yelnik AP, Simon O, Parratte B, Gracies JM. How to clinically assess and treat muscle overactivity in spastic paresis. Journal of Rehabilitation Medicine 2010;42:801-807.
55. Katz RT, Rovai GP, Brait C, Rymer WZ. Objective quantification of spastic hypertonia: Correlation with clinical findings. Archives of Physical Medicine & Rehabilitation 1992;73:339-347.
56. Gracies JM, Marosszeky JE, Renton R, Sandanam J, Gandevia SC, Burke D. Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients. Archives of Physical Medicine & Rehabilitation 2000;81:1547-1555.
57. King T. A scale for more definitive measurement of hypertonicity. Paper presented at the Occupational Therapy Forum, Stockholm, 8-12 May, 1987.
58. Copley J, Kuipers K. Management of upper limb hypertonicity. Texas: Therapy Skill Builders; 1999. p 308.
59. Gregson JM, Leathley M, Moore AP, Sharma AK, Smith TL, Watkins CL. Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Archives of Physical Medicine & Rehabilitation 1999; 80:1013-1016. (Pubitemid 29439312)
60. Granger CV, Hamilton BB, Gresham GE. The stroke rehabilitation outcome study-Part I: General description. Archives of Physical Medicine & Rehabilitation 1988;69:506-509.
61. Granger CV, Hamilton BB, Gresham GE, Kramer AA. The stroke rehabilitation outcome study: Part II. Relative merits of the total Barthel index score and a four-item subscore in predicting patient outcomes. Archives of Physical Medicine & Rehabilitation 1989; 70:100-103. (Pubitemid 19066469)
62. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: A randomised double blind placebo controlled trial. Journal of Neurology, Neurosurgery & Psychiatry 2000;69:217-221. (Pubitemid 30466027)
63. Voerman GE, Gregoric M, Hermens HJ. Neurophysiological methods for the assessment of spasticity: The Hoffmann reflex, the tendon reflex, and the stretch reflex. Disability & Rehabilitation 2005;27:33-68. (Pubitemid 40136480)
64. Bishop B, Machover S, Johnston R, Anderson M. A quantitative assessment of gamma-motoneuron contribution to the achilles tendon reflex in normal subjects. Archives of Physical Medicine & Rehabilitation 1968;49:145-154.
65. Nielsen J, Petersen N, Ballegaard M, Biering-Sørensen F, Kiehn O. H-reflexes are less depressed following muscle stretch in spastic spinal cord injured patients than in healthy subjects. Experimental Brain Research 1993;97:173-176. (Pubitemid 24045432)
66. Decq P, Filipetti P, Lefaucheur JP. Evaluation of spasticity in adults. Operative technique in Neurosurgery 2005;7:100-108. (Pubitemid 40725894)
67. Crone C, Johnsen LL, Biering-Sørensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 2003;126:495-507. (Pubitemid 36172753)
68. Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: An fMRI study. Journal of Neuroimaging 2010;20:9-15.
69. Tomásová Z, Hlustík P, Král M, Otruba P, Herzig R, Krobot A, Kanovský P. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin A. Journal of Neuroimaging 2011. Dec 30. doi: 10.1111/j.1552-6569.2011.00682.x. [Epub ahead of print].
70. Nelles G, Jentzen W, Jueptner M, Muller S, Diener HC. Arm training induced brain plasticity in stroke studied with serial positron emission tomography. Neuroimage 2001;13:1146-1154. (Pubitemid 32553545)
71. Struppler A, Binkofski F, Angerer B, Bernhardt M, Spiegel S, Drzezga A, Bartenstein P. A fronto-parietal network is mediating improvement of motor function related to repetitive peripheral magnetic stimulation: A PET-H2O15 study. Neuroimage 2007; 36(Suppl 2):T174-186. (Pubitemid 46711250)
72. Carey LM, Abbott DF, Egan GF, O'Keefe GJ, Jackson GD, Bernhardt J, Donnan GA. Evolution of brain activation with good and poor motor recovery after stroke. Neurorehabilitation & Neural Repair 2006;20:24-41. (Pubitemid 43214455)
73. Watanabe T. The role of therapy in spasticity management. American Journal of Physical Medicine & Rehabilitation 2004; 83(Suppl 10):S45-49. (Pubitemid 39281268)
74. Gracies JM. Physical modalities other than stretch in spastic hypertonia. Physical Medicine Rehabilitation Clinics of North America 2001;12:769-792, vi.
75. Bovend'Eerdt TJ, Newman M, Barker K, Dawes H, Minelli C, Wade DT. The effects of stretching in spasticity: A systematic review. Archives of Physical Medicine & Rehabilitation 2008;89: 1395-1406. (Pubitemid 351884984)
76. Harvey L, Herbert R, Crosbie J. Does stretching induce lasting increases in joint ROM? A systematic review. Physiotherapy Research International 2002;7:1-13.
77. Katalinic OM, Harvey LA, Herbert RD. Stretch for the treatment and prevention of contractures. Phys Ther 2011;91(1):11-24.
78. Watt J, Sims D, Harckham F, Schmidt L, McMillan A, Hamilton J. A prospective study of inhibitive casting as an adjunct to physiotherapy for cerebral-palsied children. Developmental Medicine & Child Neurology 1986;28:480-488. (Pubitemid 16047230)
79. Lannin NA, Novak I, Cusick A. A systematic review of upper extremity casting for children and adults with central nervous system motor disorders. Clinical Rehabilitation 2007;21:963-976. (Pubitemid 350200523)
80. Morris SL, Dodd KJ, Morris ME. Outcomes of progressive resistance strength training following stroke: A systematic review. Clinical Rehabilitation 2004;18:27-39. (Pubitemid 38111282)
81. Sunnerhagen KS, Olver J, Francisco GE. Assessing and treating functional impairment in poststroke spasticity. Neurology 2013; 80(3 Suppl 2):S35-44.
82. Bobath B. The application of physiological principles to stroke rehabilitation. Practitioner 1979;223:793-794. (Pubitemid 10167011)
83. Ansari NN, Naghdi S. The effect of Bobath approach on the excitability of the spinal alpha motor neurones in stroke patients with muscle spasticity. Electromyography & Clinical Neurophysiology 2007;47:29-36. (Pubitemid 46380456)
84. Dias D, Laíns J, Pereira A, Nunes R, Caldas J, Amaral C, Pires S, Costa A, Alves P, Moreira M, Garrido N, Loureiro L. Can we improve gait skills in chronic hemiplegics? A randomised control trial with gait trainer. Eura Medicophys 2007;43:499-504.
85. Neuhaus BE, Ascher ER, Coullon BA, Donohue MV, Einbond A, Glover JM, Goldberg SR, Takai VL. A survey of rationales for and against hand splinting in hemiplegia. American Journal of Occupational Therapy 1981;35:83-90.
86. Basaran A, Emre U, Karadavut KI, Balbaloglu O, Bulmus N. Hand splinting for poststroke spasticity: A randomized controlled trial. Topics in Stroke Rehabilitation 2012;19:329-337.
87. Alabdulwahab SS, Al-Gabbani M. Transcutaneous electrical nerve stimulation of hip adductors improves gait parameters of children with spastic diplegic cerebral palsy. NeuroRehabilitation 2010;26: 115-122.
88. Ring H, Weingarden H. Neuromodulation by functional electrical stimulation (FES) of limb paralysis after stroke. Acta Neurochirurgica Supplement 2007;97:375-380.
89. Sahin N, Ugurlu H, Albayrak I. The efficacy of electrical stimulation in reducing the post-stroke spasticity: A randomized controlled study. Disability & Rehabilitation 2012;34:151-156.
90. Lin Z, Yan T. Long-term effectiveness of neuromuscular electrical stimulation for promoting motor recovery of the upper extremity after stroke. Journal of Rehabilitation Medicine 2011;43:506-510.
91. Yan T, Hui-Chan CW. Transcutaneous electrical stimulation on acupuncture points improves muscle function in subjects after acute stroke: A randomized controlled trial. Journal of Rehabilitation Medicine 2009;41:312-316.
92. Levin MF, Hui-Chan CW. Relief of hemiparetic spasticity by TENS is associated with improvement in reflex and voluntary motor functions. Electroencephalography & Clinical Neurophysiology 1992;85:131-142.
93. Sahin N, Ugurlu H, Karahan AY. Efficacy of therapeutic ultrasound in the treatment of spasticity: A randomized controlled study. NeuroRehabilitation 2011;29:61-66.
94. Wu D, Qian L, Zorowitz RD, Zhang L, Qu Y, Yuan Y. Effects on decreasing upper-limb post-stroke muscle tone using transcranial direct current stimulation: A Randomized Sham-Controlled Study. Archives of Physical Medicine & Rehabilitation 2013;94(1):1-8.
95. Hulme A, MacLennan WJ, Ritchie RT, John VA, Shotton PA. Baclofen in the elderly stroke patient its side-effects and pharmacokinetics. European Journal of Clinical Pharmacology 1985;29: 467-469. (Pubitemid 16192605)
96. Jamous A, Kennedy P, Psychol C, Grey N. Psychological and emotional effects of the use of oral baclofen: A preliminary study. Paraplegia 1994;32:349-353. (Pubitemid 24145542)
97. Goldstein EM. Spasticity management: An overview. Journal of Child Neurology 2001;16:16-23. (Pubitemid 32218939)
98. Lapeyre E, Kuks JB, Meijler WJ. Spasticity: Revisiting the role and the individual value of several pharmacological treatments. NeuroRehabilitation 2010;27:193-200.
99. Hesse S, Werner C. Poststroke motor dysfunction and spasticity: Novel pharmacological and physical treatment strategies. CNS Drugs 2003;17:1093-1107. (Pubitemid 38021395)
100. Formica A, Verger K, Sol JM, Morralla C. [Gabapentin for spasticity: A randomized, double-blind, placebo-controlled trial]. Medicina Clinica (Barcelona) 2005;124:81-85. (Pubitemid 40293161)
101. Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs 1997;53:435-452. (Pubitemid 27117363)
102. Gelber DA, Good DC, Dromerick A, Sergay S, Richardson M. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke. Stroke 2001;32:1841-1846. (Pubitemid 32772217)
103. Whelan MA, Delgado MR. Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2010;74:336-343.
104. Olvey EL, Armstrong EP, Grizzle AJ. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: A systematic review. Clinical Therapy 2010;32: 2282-2303.
105. Zhao F, Li P, Chen SR, Louis CF, Fruen BR. Dantrolene inhibition of ryanodine receptor Ca2? release channels. Molecular mechanism and isoform selectivity. Journal of Biological Chemistry 2001;276:13810-13816.
106. Chan CH. Dantrolene sodium and hepatic injury. Neurology 1990; 40:1427-1432. (Pubitemid 20291654)
107. Elovic EP, Esquenazi A, Alter KE, Lin JL, Alfaro A, Kaelin DL. Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity. American Academy of Physical Medicine and Rehabilitation (AAPM&R) 2009;1:842-851.
108. Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, Quentin V, Marque P, Parratte B, Pellas F, Rousseaux M, Trocello JM, Uzzan M, Dumarcet N. Drug treatments for spasticity. Annals of Physical and Rehabilitation Medicine 2009; 52:746-756.
109. Patel AT. Successful treatment of long-term, poststroke, upperlimb spasticity with onabotulinumtoxinA. Physical Therapy 2011; 91:1636-1641.
110. McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, Davies L, Munns M, Hughes A. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multicentre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. Journal of Rehabilitation Medicine 2009;41:536-544.
111. Simon O, Yelnik AP. Managing spasticity with drugs. European Jornal of Physical & Rehabiliation Medicine 2010;46: 401-410.
112. Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31:2402-2406.
113. Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 2009;73:736-737; author reply 737-738.
114. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. Journal of Neurology, Neurosurgery & Psychiatry 1996;61: 265-269. (Pubitemid 26293721)
115. Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A. Botulinum neurotoxin versus tizanidine in upper limb spasticity: A placebo-controlled study. Journal of Neurology, Neurosurgery & Psychiatry 2009;80:380-385.
116. Pedreira G, Cardoso E, Melo A. Botulinum toxin type A for refractory post-stroke shoulder pain. Arquivos de Neuro-Psiquiatria 2008;66:213-215. (Pubitemid 351883904)
117. Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: International consensus statement. Eurpean Journal of Neurology 2010;17(Suppl 2):74-93.
118. Brashear A, McAfee AL, Kuhn ER, Fyffe J. Botulinum toxin type B in upper-limb poststroke spasticity: A double-blind, placebocontrolled trial. Archives of Physical Medicine & Rehabilitation 2004;85:705-709. (Pubitemid 38857904)
119. Wolf SL, Milton SB, Reiss A, Easley KA, Shenvi NV, Clark PC. Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability. Archives of Physical Medicine & Rehabilitation 2012;93:578-587.
120. Penn RD. Intrathecal baclofen for spasticity of spinal origin: Seven years of experience. Journal of Neurosurgery 1992;77:236-240.
121. Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study. Neurosurgery 2000;46:603-609; discussion 609-612.
122. Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. American Journal of Physical Medicine & Rehabilitation 2000;79:536-541.
123. Chambers HG. The surgical treatment of spasticity. Muscle & Nerve Supplement 1997;6:S121-128. (Pubitemid 128753041)
124. Farmer JP, Sabbagh AJ. Selective dorsal rhizotomies in the treatment of spasticity related to cerebral palsy. Child's Nervous System 2007;23:991-1002.
125. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle & Nerve 2005;31:535-551.
126. Satkunam LE. Rehabilitation medicine: 3. Management of adult spasticity. Canadian Medical Association Journal 2003;169: 1173-119.